Listeria Monocytogenes Infections Treatment Market By Type of Infection (Gastroenteritis, Endocarditis, Meningitis, Bacteremia, and Brain Abscess)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Key Highlights of the Report

How are the major segments performing in the Listeria Monocytogenes Infections Treatment market?

• In 2022, the Meningitis of Infection segment accounted for the largest market share. The market for treating listeria monocytogenes infections is anticipated to rise due to recent discoveries that could lead to the development of novel therapeutic approaches and significant investments by the FDA in research and development activities.

What is the Market Size of Listeria Monocytogenes Infections Treatment Value?

The global Listeria Monocytogenes Infections Treatment market is anticipated to grow at a substantial CAGR of 5.20% in the upcoming years. The global Listeria Monocytogenes Infections Treatment industry was estimated to be worth USD 4.5 billion in 2022 and was expected to be worth USD 6.41 billion by 2030.

Which Region dominated the Listeria Monocytogenes Infections Treatment market?

In 2022, the North American Region was anticipated to hold the largest global Listeria Monocytogenes Infections Treatment market share. Due to the high frequency of Listeria, North America is predicted to grow significantly in the global market for treating Listeria monocytogenes infections. For instance, the CDC notes that Listeriosis is a dangerous sickness typically brought on by consuming food tainted with the Listeria monocytogenes bacterium. Approximate estimates of the number of cases per year are 1,600 and 260 fatalities.

REPORT ATTRIBUTE	DETAILS
Listeria Monocytogenes Infections Treatment Market by Value	Yes
Listeria Monocytogenes Infections Treatment Market, Tornado Analysis	Yes
Listeria Monocytogenes Infections Treatment Market, STAR Analysis	Yes
Listeria Monocytogenes Infections Treatment Market, SRC Analysis	Yes
Listeria Monocytogenes Infections Treatment Market Pricing Analysis	Yes (On Demand)
Listeria Monocytogenes Infections Treatment Market Segment Analysis	By Type of Infection (Gastroenteritis, Endocarditis, Meningitis, Bacteremia, and Brain Abscess)
Listeria Monocytogenes Infections Treatment Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of the Middle East and Africa)
Listeria Monocytogenes Infections Treatment Market Key Companies	Teva Pharmaceutical Industries Ltd, Fresenius Kabi AG, Novartis AG, WOCKHARDT, Mylan N.V., LUPIN, Sun Pharmaceutical Industries Ltd, Novel Laboratories Inc., Hainan Poly Co. Ltd, and Amneal Pharmaceuticals LLC. Emergent BioSolutionsInc., Pfizer Inc., LimmaTech Biologics AG., GlaxoSmithKline plc., ZydusCadila., Bio
Listeria Monocytogenes Infections Treatment Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Which are the key countries in the Listeria Monocytogenes Infections Treatment market?

Numerous governmental and non-governmental groups have launched programs to aid in preventing and treating Listeriosis as its occurrence rises globally. Listeria will soon become a recognized communicable illness in China, so cases must be reported to local health officials and confirmed within 72 years. A strategy like this is anticipated to aid in treating and managing Listeriosis.

Additionally, research and development programs are predicted to have a chance to engage in the worldwide Listeria monocytogenes treatment market in China and India due to the expected unmet medical need.

How is the economy impacting the global Listeria Monocytogenes Infections Treatment growth?

Some hospitals and clinics may have restricted capacity or delay non-urgent treatments, such as those associated with detecting and treating Listeria monocytogenes infections, as a result of the COVID-19 pandemic’s burden on healthcare systems. Furthermore, given that both infections can produce respiratory symptoms and may affect those with compromised immune systems, some patients with Listeria monocytogenes infections may be at a higher risk of developing severe disease if detected with COVID-19.

What is the competitive environment of the Listeria Monocytogenes Infections Treatment market?

The market for treating listeria monocytogenes infections is anticipated to rise due to recent discoveries that could lead to the development of novel therapeutic approaches and significant investments by the FDA in research and development activities. For instance, a study published in ScienceDirect found that the gram-positive bacterium Listeria monocytogenes is responsible for life-threatening infections in older and immunosuppressed hosts. The recommended antibiotics for treating Listeria infections are gentamicin, ampicillin, amoxicillin, and penicillin. According to reports, new fluoroquinolones may work well in animal models and in vitro. New fluoroquinolones, particularly levofloxacin, may offer a therapeutic alternative for Listeria infection, while more research is necessary.

Executive Summary

What are the key trends in the Listeria Monocytogenes Infections Treatment market?

• The global market for Listeria monocytogenes treatments is driven by increased foodborne diseases. The prevalence of Listeriosis has increased due to increased consumption of frozen foods such as vegetables, meat, and dairy products.
• Listeriosis can cause meningitis or septicemia in patients with weakened immune systems. It might also cause pregnant women to miscarry. Listeria is the third most common cause of mortality in the United States, according to the Centers for Disease Control and Prevention (CDC). Clinicians noted a rise in the incidence of adult meningitis and newborn sepsis caused by Listeria monocytogenes in 2017.

How are Growing Need for Drugs Affecting the Growth of the Listeria Monocytogenes Infections Treatment Market?

Listeriosis is a dangerous bacterial infection from the rod-shaped bacterium Listeria monocytogenes, often known as foodborne bacterial sickness. For those who have weakened immune systems or are pregnant, the infection has the potential to be lethal. Water, deli meats that have been processed, and unpasteurized milk products are the usual sources of the sickness.  One of the key factors fueling the growth of the market for treating listeriosis infections is the rise in the number of persons affected by the condition worldwide. The high demand for medications like ampicillin, Gentamicin, Vancomycin, and others and rising rates of foodborne bacterial infection, particularly in pregnant women who are more likely to get Listeriosis from eating contaminated food, stimulate market expansion.

Which are the key investments by the Listeria Monocytogenes Infections Treatment market players?

Businesses are investing extensively and engaging in research and development initiatives. Both government and non-government organizations are carrying out R&D efforts. The U.S. Department of Agriculture has awarded microbiologists in Penn State’s College of Agricultural Sciences $605,000 to research how microbial biofilms shield Listeria monocytogenes, the bacteria that causes the fatal foodborne illness listeriosis. They will use the grant from the National Institute of Food and Agriculture USDA to research the interactions between Listeria monocytogenes and microorganisms in fruit-packing conditions.

Some major players in the Listeria Monocytogenes Infections Treatment market are Emergent Bio Solutions Inc, Pfizer Inc, LimmaTech Biologics AG, GlaxoSmithKline plc, ZydusCadila, Bionpharma, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Fresenius Kabi AG, Novartis AG, WOCKHARDT, Mylan N.V., LUPIN, Sun Pharmaceutical Industries Ltd, Novel Laboratories Inc., Hainan Poly Co. Ltd, and Amneal Pharmaceuticals LLC.

What are the Major Driving Factors for the Listeria Monocytogenes Infections Treatment Market?

The rising prevalence of foodborne diseases drives the global market for listeriosis treatments. Increased use of frozen items such as meat, dairy, and vegetables is a factor in the rise in listeriosis cases. The global listeriosis therapy market is also driven by rising awareness of the condition’s treatment and prevention methods. The market for treating listeria monocytogenes infections is anticipated to expand due to rising infection rates and government initiatives aimed at prevention and treatment measurement.

What are the Major Risks for the Listeria Monocytogenes Infections Treatment Market?

It is anticipated that a lack of unique, disease-specific treatments and poor healthcare spending in several emerging nations may restrain market expansion. During the projection period, strict and burdensome regulations are anticipated to challenge the market for treating listeriosis infections.

Which is the key application in the Listeria Monocytogenes Infections Treatment market?

During the forecast period, the Monocytogenes segment will hold a prominent share in the global Listeria Monocytogenes Infections Treatment market. The most frequent infection caused by Listeria monocytogenes is meningitis. Approximately 90% of reported Listeria infections in the United States, according to the Centers for Disease Control and Prevention (CDC), are invasive, meaning they involve a bloodstream infection or another serious condition, including meningitis or brain abscess. In addition, meningitis was the most frequent clinical manifestation of 143 instances of invasive Listeriosis, accounting for 67% of cases, according to a study published in the Journal of Clinical Microbiology. With 17% of patients, bacteremia was the second most prevalent condition.

How is the Listeria Monocytogenes Infections Treatment market performing in regions?

Europe is another region projected to follow North America’s market trajectory in the coming years. Infections with Listeria monocytogenes are rather prevalent in Europe. In 2018, 2,480 confirmed cases of Listeriosis were reported in the European Union, with a case-fatality rate of 20.9%, according to a report by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). Consuming contaminated food products, especially ready-to-eat foods that have not been properly prepared or kept, is one such factor. Several significant listeriosis outbreaks have occurred in Europe, and they have been connected to tainted dairy, meat, and fish items, including cheese. The aging population in Europe also contributes to the greater frequency of Listeriosis. People’s immune systems deteriorate with age, rendering them more vulnerable to life-threatening illnesses like Listeriosis.

What is the regulatory landscape for the Listeria Monocytogenes Infections Treatment market?

The appropriate regulatory body, such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA), must approve antibiotics to treat Listeria monocytogenes infections. The safety and effectiveness of the drug for its intended purpose must be proven by substantial data from preclinical and clinical trials for drug manufacturers to receive approval. The use of antibiotics to treat Listeria monocytogenes infections is regulated by regulatory approval in addition to public health authority guidelines and recommendations. As an illustration, the US Centers for Disease Control and Prevention (CDC) offer recommendations on the use of drugs for treating Listeriosis, including the drugs suggested for certain patient demographics.

What are the major players planning for the future of the Listeria Monocytogenes Infections Treatment market?

Global market growth is anticipated to be driven by rising incidence rates of Listeriosis and growing public awareness of the disease. Healthcare service providers and R&D programs should invest in listeriosis treatment due to the unmet medical need.

Segmentation of Global Listeria Monocytogenes Infections Treatment Market-

Global Listeria Monocytogenes Infections Treatment Market – By Type of Infection

• Gastroenteritis
• Endocarditis
• Meningitis
• Bacteremia
• Brain Abscess

Global Listeria Monocytogenes Infections Treatment Market – By Region

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Listeria Monocytogenes Infections Treatment Market
2.2. Global Listeria Monocytogenes Infections Treatment Market, By Type of Infection
2.3. Global Listeria Monocytogenes Infections Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Listeria Monocytogenes Infections Treatment Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Infection
3.5.2. Application
3.5.3. End-user
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Type of Infection Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Listeria Monocytogenes Infections Treatment Market, By Type of Infection
7.1. Global Listeria Monocytogenes Infections Treatment Market Overview, by Type of Infection
7.1.1. Global Listeria Monocytogenes Infections Treatment Market Revenue Share, By Type of Infection, 2022 Vs 2030 (in %)
7.2. Gastroenteritis
7.2.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2017-2030 (US$ Bn)
7.3. Endocarditis
7.3.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2017-2030 (US$ Bn)
7.4. Meningitis
7.4.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2017-2030 (US$ Bn)
7.5. Bacteremia
7.5.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2017-2030 (US$ Bn)
7.6. Brain Abscess
7.6.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2017-2030 (US$ Bn)

8. Global Listeria Monocytogenes Infections Treatment Market, By Region
8.1. Global Listeria Monocytogenes Infections Treatment Market Overview, by Region
8.1.1. Global Listeria Monocytogenes Infections Treatment Market, By Region, 2022 vs 2030 (in%)
8.2. Type of Infection
8.2.1. Global Listeria Monocytogenes Infections Treatment Market, By Type of Infection, 2017-2030 (US$ Bn)

9. North America Listeria Monocytogenes Infections Treatment Market Analysis
9.1. North America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. North America Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2030 (US$ Bn)
9.2.1. North America Listeria Monocytogenes Infections Treatment Market, by Country, 2022 Vs 2030 (in%)
9.2.2. U.S.
9.2.2.1. U.S. Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.2.2. U.S. Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
9.2.3. Canada
9.2.3.1. Canada Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.3.2. Canada Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
9.2.4. Mexico
9.2.4.1. Mexico Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.4.2. Mexico Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)

10. Europe Listeria Monocytogenes Infections Treatment Market Analysis
10.1. Europe Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Europe Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2030 (US$ Bn)
10.2.1. Europe Listeria Monocytogenes Infections Treatment Market, by Country, 2022 Vs 2030 (in%)
10.2.2. Germany
10.2.2.1. Germany Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.2.2. Germany Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
10.2.3. France
10.2.3.1. France Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.3.2. France Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
10.2.4. UK
10.2.4.1. UK Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.4.2. UK Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
10.2.5. Italy
10.2.5.1. Italy Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.5.2. Italy Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
10.2.6. Spain
10.2.6.1. Spain Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.6.2. Spain Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
10.2.7. Rest of Europe
10.2.7.1. Rest of Europe Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.7.2. Rest of Europe Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)

11. Asia Pacific Listeria Monocytogenes Infections Treatment Market Analysis
11.1. Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2030 (US$ Bn)
11.2.1. Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Country, 2022 Vs 2030 (in%)
11.2.2. China
11.2.2.1. China Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.2.2. China Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
11.2.3. Japan
11.2.3.1. Japan Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.3.2. Japan Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
11.2.4. India
11.2.4.1. India Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.4.2. India Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
11.2.5. South Korea
11.2.5.1. South Korea Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.5.2. South Korea Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
11.2.6. South-East Asia
11.2.6.1. South-East Asia Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.6.2. South-East Asia Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
11.2.7. Rest of Asia Pacific
11.2.7.1. Rest of Asia Pacific Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.7.2. Rest of Asia Pacific Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)

12. Latin America Listeria Monocytogenes Infections Treatment Market Analysis
12.1. Latin America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Latin America Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2030 (US$ Bn)
12.2.1. Latin America Listeria Monocytogenes Infections Treatment Market, by Country, 2022 Vs 2030 (in%)
12.2.2. Brazil
12.2.2.1. Brazil Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.2.2. Brazil Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
12.2.3. Argentina
12.2.3.1. Argentina Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.3.2. Argentina Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
12.2.4. Rest of Latin America
12.2.4.1. Rest of Latin America Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.4.2. Rest of Latin America Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)

13. Middle East and Africa Listeria Monocytogenes Infections Treatment Market Analysis
13.1. Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2030 (US$ Bn)
13.2.1. Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Country, 2022 Vs 2030 (in%)
13.2.2. GCC Countries
13.2.2.1. GCC Countries Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.2.2. GCC Countries Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
13.2.3. South Africa
13.2.3.1. South Africa Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.3.2. South Africa Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)
13.2.4. Rest of Middle East and Africa
13.2.4.1. Rest of Middle East and Africa Listeria Monocytogenes Infections Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.4.2. Rest of Middle East and Africa Listeria Monocytogenes Infections Treatment, By Type of Infection, 2017-2030 (US$ Bn)

14. Company Profiles
14.1. Emergent BioSolutionsInc
14.1.1. Company Overview
14.1.2. Products/Services Portfolio
14.1.3. Geographical Presence
14.1.4. Financial Summary
14.1.4.1. Market Revenue and Net Profit (2019-2022)
14.1.4.2. Business Segment Revenue Analysis
14.1.4.3. Geographical Revenue Analysis
14.2. Pfizer Inc
14.3. LimmaTech Biologics AG
14.4. GlaxoSmithKline plc
14.5. ZydusCadila
14.6. Bionpharma
14.7. AurobindoPharma
14.8. Teva Pharmaceutical Industries Ltd
14.9. Fresenius Kabi AG
14.10. Novartis AG
14.11. WOCKHARDT
14.12. Mylan N.V.
14.13. LUPIN
14.14. Sun Pharmaceutical Industries Ltd
14.15. Novel Laboratories Inc.
14.16. Hainan Poly Co. Ltd
14.17. Amneal Pharmaceuticals LLC

 

List of Figures
FIG. 1 Global Listeria Monocytogenes Infections Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Listeria Monocytogenes Infections Treatment Market Segmentation
FIG. 4 Global Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2022 (US$ Bn)
FIG. 5 Global Listeria Monocytogenes Infections Treatment Market, by Geography, 2022 (US$ Bn)
FIG. 6 Attractive Investment Proposition, by Type of Infection, 2022
FIG. 7 Attractive Investment Proposition, by Geography, 2022
FIG. 8 Global Market Share Analysis of Key Listeria Monocytogenes Infections Treatment Market Manufacturers, 2022
FIG. 9 Global Market Positioning of Key Listeria Monocytogenes Infections Treatment Market Manufacturers, 2022
FIG. 10 Global Listeria Monocytogenes Infections Treatment Market Value Contribution, By Type of Infection, 2022 & 2030 (Value %)
FIG. 11 Global Listeria Monocytogenes Infections Treatment Market, by Gastroenteritis, Value, 2017-2030 (US$ Bn)
FIG. 12 Global Listeria Monocytogenes Infections Treatment Market, by Endocarditis, Value, 2017-2030 (US$ Bn)
FIG. 13 Global Listeria Monocytogenes Infections Treatment Market, by Meningitis, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Listeria Monocytogenes Infections Treatment Market, by Bacteremia, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Listeria Monocytogenes Infections Treatment Market, by Brain Abscess, Value, 2017-2030 (US$ Bn)
FIG. 16 North America Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 17 U.S. Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 18 Canada Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 19 Europe Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 20 Germany Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 21 France Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 22 U.K. Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 23 Italy Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 24 Spain Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 25 Rest of Europe Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 26 Asia Pacific Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 27 China Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 28 Japan Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 29 India Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 30 South Korea Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 31 South-East Asia Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 32 Rest of Asia Pacific Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 33 Latin America Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 34 Brazil Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 35 Mexico Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 36 Rest of Latin America Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 37 Middle East & Africa Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 38 GCC Countries Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 39 South Africa Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)
FIG. 40 Rest of Middle East and Africa Listeria Monocytogenes Infections Treatment Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Listeria Monocytogenes Infections Treatment Market
TABLE 2 Global Listeria Monocytogenes Infections Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Listeria Monocytogenes Infections Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Listeria Monocytogenes Infections Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Listeria Monocytogenes Infections Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Listeria Monocytogenes Infections Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Listeria Monocytogenes Infections Treatment Market, by Gastroenteritis, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Listeria Monocytogenes Infections Treatment Market, by Gastroenteritis, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Listeria Monocytogenes Infections Treatment Market, by Endocarditis, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Listeria Monocytogenes Infections Treatment Market, by Endocarditis, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Listeria Monocytogenes Infections Treatment Market, by Meningitis, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Listeria Monocytogenes Infections Treatment Market, by Meningitis, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Listeria Monocytogenes Infections Treatment Market, by Bacteremia, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Listeria Monocytogenes Infections Treatment Market, by Bacteremia, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Listeria Monocytogenes Infections Treatment Market, by Brain Abscess, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Listeria Monocytogenes Infections Treatment Market, by Brain Abscess, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 18 Global Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 19 Global Listeria Monocytogenes Infections Treatment Market, by Region, 2017-2022 (US$ Bn)
TABLE 20 Global Listeria Monocytogenes Infections Treatment Market, by Region, 2023-2030 (US$ Bn)
TABLE 21 North America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 22 North America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 23 North America Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 24 North America Listeria Monocytogenes Infections Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 25 United States Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 26 United States Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 27 Canada Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 28 Canada Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 29 Mexico Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 30 Mexico Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 31 Europe Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 32 Europe Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 33 Europe Listeria Monocytogenes Infections Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 34 Europe Listeria Monocytogenes Infections Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 35 Germany Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 36 Germany Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 37 France Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 38 France Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 39 United Kingdom Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 40 United Kingdom Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 41 Italy Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 42 Italy Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 43 Spain Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 44 Spain Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 45 Rest of Europe Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 46 Rest of Europe Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 47 Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 48 Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 49 China Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 50 China Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 51 Japan Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 52 Japan Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 53 India Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 54 India Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 55 South Korea Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 56 South Korea Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 57 South-East Asia Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 58 South-East Asia Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 59 Rest of Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 60 Rest of Asia Pacific Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 61 Latin America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 62 Latin America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 63 Brazil Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 64 Brazil Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 65 Argentina Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 66 Argentina Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 67 Rest of Latin America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 68 Rest of Latin America Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 69 Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 70 Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 71 GCC Countries Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 72 GCC Countries Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 73 South Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 74 South Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)
TABLE 75 Rest of Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2017-2022 (US$ Bn)
TABLE 76 Rest of Middle East and Africa Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2023-2030 (US$ Bn)